OIL · ASX

Optiscan Imaging Limited (ASX:OIL)

AU$0.17

 0.0 (0.0%)
ASX:Live
25/12/2024 12:00:00 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

OIL Overview

OIL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About OIL

Website

Optiscan Imaging Limited

Telephone

61.3.9538.3333

Address

16 Miles Street Mulgrave, Victoria (VIC) 3170

Description

Optiscan Imaging Ltd. is engaged in the development of endomicroscopic imaging technologies for medical, translational and pre-clinical applications. It has developed and patented miniaturised confocal microscopes. Its products include FIVE2 and Customisation options. The company was founded by Martin Harris and Peter Maxwell Delaney in 1994 and is headquartered in Mulgrave, Australia.

OIL Price Chart

Key Stats

Market Cap

AU$142.01M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.07 - 0.26

Trade Value (12mth)

AU$10,516.00

1 week

0%

1 month

3.03%

YTD

100%

1 year

109.88%

All time high

0.65

Key Fundamentals

EPS 3 yr Growth

105.60%

EBITDA Margin

-679.10%

Operating Cashflow

-$6m

Free Cash Flow Return

-67.20%

ROIC

-70.90%

Interest Coverage

-331.00

Quick Ratio

7.40

Other Data

Shares on Issue (Fully Dilluted)

835m

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

OIL Announcements

Latest Announcements

Date Announcements

06 December 24

Change in substantial holding

×

Change in substantial holding

21 November 24

OIL Managing Director's Presentation & Chair's Address

×

OIL Managing Director's Presentation & Chair's Address

21 November 24

Results of Annual General Meeting

×

Results of Annual General Meeting

18 November 24

Optiscan Signs Research Agreement with Minnesota Vet College

×

Optiscan Signs Research Agreement with Minnesota Vet College

04 November 24

Optiscan Signs Agreement with Monash to Progress GI Scope

×

Optiscan Signs Agreement with Monash to Progress GI Scope

31 October 24

OIL September 2024 Quarterly Report and Appendix 4C

×

OIL September 2024 Quarterly Report and Appendix 4C

28 October 24

Optiscan Participates in Major US Industry Events

×

Optiscan Participates in Major US Industry Events

21 October 24

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

21 October 24

2024 AGM - Letter to Shareholders & Proxy Form

×

2024 AGM - Letter to Shareholders & Proxy Form

07 October 24

Annual General Meeting Date

×

Annual General Meeting Date

30 August 24

Appendix 4E Preliminary Final Report

×

Appendix 4E Preliminary Final Report

30 August 24

OIL 2024 Annual Report

×

OIL 2024 Annual Report

30 August 24

Appendix 4G & Corporate Governance Statement

×

Appendix 4G & Corporate Governance Statement

19 August 24

Optiscan Signs MOU with University of Minnesota

×

Optiscan Signs MOU with University of Minnesota

31 July 24

OIL June 2024 Quarterly Report and Appendix 4C

×

OIL June 2024 Quarterly Report and Appendix 4C

29 July 24

Optiscan Delivers Major Milestone in Telepathology Platform

×

Optiscan Delivers Major Milestone in Telepathology Platform

15 July 24

Optiscan Receives Ethical Clearance for Breast Cancer Study

×

Optiscan Receives Ethical Clearance for Breast Cancer Study

12 July 24

Notification regarding unquoted securities - OIL

×

Notification regarding unquoted securities - OIL

01 July 24

Optiscan 2024 Roadshow Presentation

×

Optiscan 2024 Roadshow Presentation

04 June 24

Optiscan Reveals InVue Imaging Device for Precision Surgery

×

Optiscan Reveals InVue Imaging Device for Precision Surgery

16 May 24

Optiscan Webinar Investor Presentation

×

Optiscan Webinar Investor Presentation

13 May 24

Optiscan Signs Know-How Agreement with Mayo Clinic

×

Optiscan Signs Know-How Agreement with Mayo Clinic

13 May 24

Optiscan Webinar Following Mayo Clinic Agreement

×

Optiscan Webinar Following Mayo Clinic Agreement

30 April 24

OIL March 2024 Quarterly Report and Appendix 4C

×

OIL March 2024 Quarterly Report and Appendix 4C

17 April 24

Change in substantial holding

×

Change in substantial holding

OIL Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -86.1 -4.5 -5.7 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -112.4 -2.4 -7.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -5.8 -6.6 -3.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.00 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.00 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -35.8 -60.3 296.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 631 623 823 Lock Lock Lock
Basic m Lock Lock Lock Lock 631 623 823 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 1 2 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 13.9 65.9 -31.2 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 6 8 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -2 1 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -329.5 131.1 -132.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -163.6 30.6 -14.5 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 264 69 114 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -5 -5 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -50.0 6.1 -59.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -516.0 -292.2 -679.1 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -5 -5 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -46.9 3.3 -59.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -539.8 -314.7 -728.2 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -5 -5 -7 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -4 -4 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -99.0 -2.8 -39.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -417.9 -259.0 -524.4 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -4 -3 -6 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 -5 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 0 16 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -4 -3 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -83.5 17.1 -77.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3.9 -2.0 -5.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 5 1 6 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 8 5 16 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -4 0 -6 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 2 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 7 3 14 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 7 3 14 Lock Lock Lock
     Growth % Lock Lock Lock Lock -35.0 -53.7 330.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -53.0 -93.1 -38.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -64.2 -142.9 -43.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -60.7 -99.8 -95.9 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -47.9 -85.4 -70.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -43.4 -61.9 -67.2 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -162.6 -152.0 -331.0 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.8 0.1 0.7 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -60.4 -15.2 -42.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 7.3 2.6 8.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 6.1 1.6 7.4 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 61.9 24.0 40.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -383.2 -221.5 -327.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.8 1.4 0.9 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 2.2 0.9 0.8 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.2 0.8 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 29.9 31.2 46.7 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.1 0.4 0.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.1 0.4 0.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -510.8 -302.9 -610.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -64.8 -108.9 -45.1 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -53.0 -93.1 -38.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.5 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -64.2 -142.9 -43.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -64.2 -142.9 -43.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 166.1 423.9 474.2 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 478.7 259.5 401.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 644.7 683.3 875.9 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 46.0 113.3 103.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 598.8 570.1 772.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

OIL Shortsell

Frequently Asked Questions

The current share price of Optiscan Imaging Limited (OIL:ASX) is AU$0.17.
The 52-week high share price for Optiscan Imaging Limited (OIL:ASX) is AU$0.26.
The 52-week low share price for Optiscan Imaging Limited (OIL:ASX)? is AU$0.07.
Optiscan Imaging Limited (OIL:ASX) does not pay a dividend.
Optiscan Imaging Limited (OIL:ASX) does not pay a dividend.
Optiscan Imaging Limited (OIL:ASX) has a franking level of 0.0%.
Optiscan Imaging Limited (OIL:ASX) is classified in the Healthcare.
The current P/E ratio for Optiscan Imaging Limited (OIL:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.